# Final Review (GPT-5-mini)

**Purpose:** Log the paper's final state after all revisions
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-03T08:33:18.540328
**Route:** OpenRouter + LaTeX
**Tokens:** 20646 in / 6152 out
**Response SHA256:** 18008a35f4143904

---

Summary
This is an interesting and policy-relevant paper asking whether state Energy Efficiency Resource Standards (EERS) reduce electricity consumption. The author assembles a long state × year panel (1990–2023), codes staggered adoption across 28 treated jurisdictions, and employs modern staggered-DiD tools (Callaway & Sant'Anna (CS-DiD), Sun–Abraham, Synthetic DiD) to estimate dynamic effects. The headline is an overall ATT of −4.15 log points (~4.2%) on per‑capita residential electricity consumption (CS-DiD, p<0.01), with event‑study dynamics that grow over time. The paper also conducts a welfare back‑of‑the‑envelope calculation and several robustness checks.

At high level: the paper has promise and addresses an important question with suitable modern tools. However, before a top general-interest journal would consider publication, the manuscript needs substantive revisions to strengthen inference, clarify identification, improve robustness and transparency, deepen literature engagement, and polish presentation. Below I give a detailed, rigorous review following your requested checklist.

1. FORMAT CHECK (explicit, demanding)
- Length: The LaTeX source includes main text plus appendices. Judging by content density, figures/tables, and appendices, the manuscript appears to exceed 25 pages (main text + appendix likely ~40+ pages). (I cannot see final PDF page numbers; authors should state the exact page count excluding references/appendix in the cover letter and ensure main text ≥25 pages as required.)
- References: The bibliography is extensive on DiD and energy topics and already cites many relevant papers (Callaway & Sant'Anna, Goodman‑Bacon, Sun & Abraham, Arkhangelsky et al., Rambachan & Roth, Fowlie et al., Allcott, etc.). But some foundational and methodological works are missing (see Section 4 below for concrete missing citations and BibTeX entries).
- Prose: Major sections (Introduction, Institutional Background, Conceptual Framework, Data, Empirical Strategy, Results, Robustness, Heterogeneity, Discussion, Conclusion) are written in paragraph form, not bullets. The paper overall reads like a standard academic article.
- Section depth: Some major sections are well developed (Introduction, Data, Empirical Strategy, Results, Robustness). A few subsections are relatively short (e.g., some parts of Institutional Background and parts of Heterogeneity and Discussion have only 1–2 substantive paragraphs). Top journals usually expect each major section to contain sustained development (3+ substantive paragraphs) especially Methods, Results, Discussion. Please expand the shorter subsections (see specific notes below).
- Figures: The LaTeX references figures (fig1, fig2, fig3, etc.). I could not inspect the actual image files from the TeX source, so I cannot confirm axes, ticks, legend readability, or whether raw data are plotted. Check every figure in the compiled PDF: all axes must be labeled (including units), legends and sample sizes displayed or described in notes, confidence intervals clearly shown, fonts legible, and each figure caption must be self-contained (what estimator, control group, sample used, and N). For event‑study figures explicitly state the base period and number of cohorts contributing to each event time (it is partially discussed in the text, but must also be in the caption).
- Tables: The tables in the source include real numbers, standard errors, and CIs (no placeholders). Table notes need to explicitly state sample period, outcome definition, estimator, clustering, and how CI/SEs were computed (bootstrap? analytical?). Several table notes already do this; ensure consistency across all tables.

2. STATISTICAL METHODOLOGY (critical)
This is the central part of my review. A paper cannot pass without proper statistical inference; the paper does many things correctly but several important issues remain.

a) Standard errors
- Good: Every reported coefficient in main tables (Table 3 / Table~\ref{tab:main_results}) is accompanied by standard errors in parentheses and 95% CIs in brackets. The author clusters standard errors at the state level and mentions wild cluster bootstrap for the TWFE specification (p. ~32 "Inference with Few Clusters").
- Concern: For the preferred CS‑DiD estimator, the paper relies on the (analytical) standard errors produced by the did package. Given the finite number of clusters (51 states) and especially imbalanced treated vs control counts, I recommend conducting and reporting alternative inference methods for the CS‑DiD estimates:
  - cluster bootstrap or clustered wild bootstrap appropriate for the CS estimator (e.g., clustered multiplier bootstrap for group‑time ATTs or bootstrap aggregation used by Callaway & Sant'Anna implementations);
  - randomization (permutation) inference over treatment timing or treated units (placebo permutations), which is particularly helpful with few clusters;
  - t‑critical adjustments (e.g., use of t_{G−1} for small number of clusters) or reporting of p‑values from wild cluster bootstrap.
- The paper reports wild cluster bootstrap only for TWFE and not for CS‑DiD; this must be fixed. The strong p‑value difference (TWFE bootstrap p ≈ 0.14 vs CS‑DiD analytical p<0.01) is alarming and must be reconciled. Provide bootstrap p‑values and CIs for the CS‑DiD aggregated ATT and for key event‑time estimates (especially long horizons).

b) Significance testing
- The paper reports p‑values and star notation. But be explicit about multiple hypothesis testing for event studies: you estimate many event‑time coefficients (−10..+15); address multiple comparisons (e.g., use joint tests for pre‑trends, or present uniform confidence bands / familywise error control). Rambachan & Roth (2023) is cited for sensitivity — include formal joint pre‑trend tests (and report p‑values) as per Roth (2022) recommendations.

c) Confidence intervals
- Main results include 95% CIs (Table~\ref{tab:main_results}); good. But when presenting event‑study dynamics, show confidence bands (preferably uniform bands) and state clearly whether they are pointwise or uniform (pointwise are weaker).

d) Sample sizes
- N (observations), number of treated states, and number of control states are reported in Table~\ref{tab:main_results}: Observations = 1479, Treated States = 28, Control States = 23. Good. But for event‑time and cohort plots, explicitly report how many cohorts / how many states contribute to each event time on the figure or in the caption. For group-level ATT plots, explicitly state which cohorts were omitted and why (you do mention bootstrap non‑convergence for single-state cohorts; but be explicit in captions and in a short footnote listing which specific cohorts were omitted).

e) DiD with staggered adoption
- The author correctly uses Callaway & Sant'Anna (2021) and discusses Goodman‑Bacon contamination; this is appropriate and required. The paper also shows Sun–Abraham and SDID comparisons. Good.
- Concern: In several parts you aggregate long‑horizon event‑time estimates (e.g., event time 10–15) that are identified primarily from a small number of early cohorts, and some cohorts are singletons (1998 CT, etc.). You explicitly note that bootstrapped inference did not converge for single‑unit cohorts and thus they are omitted from figures (p. ~23). This raises two problems:
  1. Long‑run event‑time estimates are supported by few clusters (sometimes 1–3 states), so inference is fragile. You do present Rambachan–Roth sensitivity analysis, which is good and shows fragility. Still, you should prominently emphasize that long‑horizon estimates are weakly identified and avoid strong claims about magnitudes at event times 10–15.
  2. For cohorts with 1 treated state, CS‑DiD group‑level inference is unreliable. Consider reporting aggregated estimands that exclude singletons, or else use alternative inference (permutation/placebo) to obtain finite‑sample valid p‑values, or explicitly show how much the aggregate ATT depends on the early singletons by leave‑one‑out analysis.
- Recommendation: Present the main ATT (aggregate across cohorts and post periods) as the primary causal claim, but downweight or qualify long‑run claims. Add leave‑one‑out aggregated ATTs (exclude earliest cohorts one at a time) and report sensitivity of overall ATT.

f) RDD
- Not applicable. (No RDD in this paper.) Note: the checklist required RDD-specific tests only if RDD is used.

Bottom line on methodology: The paper largely uses appropriate modern methods, but statistical inference is not yet robust enough for a top general interest journal. The CS‑DiD analytical SEs must be supplemented with bootstrap/wild bootstrap/permutation inference; pre‑trend joint tests and multiple‑comparison adjustments must be added; long‑horizon estimates must be presented with much more caution. If these are not addressed, the paper is unpublishable in a top journal. I state this clearly: unaddressed inference fragility and over‑reliance on long‑horizon estimates identified by few units make the current manuscript not acceptable for publication.

3. IDENTIFICATION STRATEGY
- Credibility: The design (staggered adoption across states with many never‑treated controls) is appropriate. The author carefully states the parallel trends assumption (Section 5). Using never‑treated states as controls and employing CS‑DiD is the right approach.
- Evidence for assumptions:
  - Event study (Figure~\ref{fig:event_study}) is presented and shown to have flat pre‑treatment coefficients in text. But I request formal pre‑trend joint tests (e.g., F‑tests on all lead coefficients jointly equal zero, permutation tests on leads) and presentation of p‑values. Visual evidence alone is insufficient.
  - Placebo tests: The author reports a placebo outcome (industrial electricity) and notes no effect; but the full results and p‑values for that placebo are not shown in main tables or appendix figures in detail. Report the placebo regression table and event study in the appendix with inference.
  - Anticipation: You check for immediate pre‑treatment effects but must show whether utilities advertised programs or pre‑existing pilot programs could create anticipation. Consider coding a pre‑treatment indicator for official program initiation vs legislative adoption year if such dates are available; many policies are passed but take effect later, and implementation may begin earlier—this matters for timing.
- Threats:
  - Concurrent policies: The author controls for RPS and decoupling, and interprets estimates as the “EERS package.” Still, correlated policy adoption is an important threat. I recommend a) including a flexible control for the timing of major related policies (building code updates, appliance standards, major federal/state incentives), and b) showing results restricting to states without major concurrent policy changes in a ±3 year window around EERS adoption (a subsample robustness).
  - Composition effects: You run a placebo on industrial electricity to argue effects are not compositional. Also consider testing for employment / output shifts in energy‑intensive industries around adoption (BLS county/state industry employment series) to further rule out compositional change.
  - Differential regional trends: You use region (census division) × year fixed effects in a robustness check, which is good. Also consider state‑specific linear trends as a robustness check, and the Rambachan–Roth sensitivity bound framework (you already do — good). Present results with state linear trends and with higher‑order trends (quadratic) to show robustness.
- Mechanisms: The conceptual framework identifies channels (programs, info, market transformation, rebound, free‑rider). Because the paper cannot observe participation, it cannot decompose program vs spillover effects. The paper acknowledges this limitation; but it would be stronger to:
  - Use available state‑level DSM program spending or savings (EIA Form 861 or ACEEE program spending datasets) to run dose‑response regressions (intensity of treatment) or event studies that use continuous treatment intensity (program spending per capita or targeted annual % savings). This addresses heterogeneity by intensity and links to mechanism.
  - If EIA Form 861 data quality is heterogeneous, present at least a bounding exercise for dose‑response using available years/states where data quality is good.

4. LITERATURE (missing references and positioning)
- The paper cites major DiD and energy evaluation literature, but several foundational or closely related works are missing and should be cited and discussed:
  1. Synthetic Control foundational paper:
     - Abadie, Diamond & Hainmueller (2010). Relevant because you use SDID and compare to synthetic controls; the synthetic control literature’s properties matter for interpretation.
  2. Imbens & Lemieux (2008), Lee & Lemieux (2010) — canonical references on RDD and quasi‑experimental methods. Even if you do not use RDD, Lee & Lemieux (2010) and Imbens & Lemieux are often cited when discussing identification in program evaluation and event studies.
  3. Ferman, Pinto, and Possebom (2019/2021) — papers that discuss inference and bias in synthetic control and staggered DiD settings (depending on exact citation). These works discuss how few control units and poor pre‑trend fit make inference problematic.
  4. Papers on inference with few clusters and permutation: Conley & Taber (2011) and others are cited, but also consider citing recent methodological work on permutation tests in staggered DiD (e.g., Cattaneo, Idrobo and Titiunik work on permutation inference for synthetic control / DiD).
  5. More energy‑policy program evaluation papers: You cite Fowlie et al. (2018) and others; consider adding more evaluations of weatherization, utility programs, and engineering vs econometric gaps (to better situate your “engineering‑econometric gap” claim).
- Provide specific BibTeX entries (requested). I supply the most critical missing references below with BibTeX and a short note on why each is relevant:

Suggested missing references (BibTeX)
- Abadie, Diamond & Hainmueller (2010): synthetic control foundational method used for comparisons.
```bibtex
@article{abadie2010,
  author = {Abadie, Alberto and Diamond, Alexis and Hainmueller, Jens},
  title = {Synthetic Control Methods for Comparative Case Studies: Estimating the Effect of California’s Tobacco Control Program},
  journal = {Journal of the American Statistical Association},
  year = {2010},
  volume = {105},
  pages = {493--505}
}
```
- Imbens & Lemieux (2008): canonical discussion of RD and natural experiments (relevant background for identification discussions and pre‑trend testing).
```bibtex
@article{imbens2008,
  author = {Imbens, Guido W. and Lemieux, Thomas},
  title = {Regression Discontinuity Designs: A Guide to Practice},
  journal = {Journal of Econometrics},
  year = {2008},
  volume = {142},
  pages = {615--635}
}
```
- Lee & Lemieux (2010): RDD survey; useful when discussing quasi‑experimental identification more broadly.
```bibtex
@article{lee2010,
  author = {Lee, David S. and Lemieux, Thomas},
  title = {Regression Discontinuity Designs in Economics},
  journal = {Journal of Economic Literature},
  year = {2010},
  volume = {48},
  pages = {281--355}
}
```
- Ferman, Pinto & Possebom (2019): inference and bias in SCM / issues with small samples.
```bibtex
@article{ferman2019,
  author = {Ferman, Bruno and Pinto, Christina and Possebom, Vanderlei},
  title = {Inference in Synthetic Control Methods with Few Pre-treatment Periods},
  journal = {Review of Economics and Statistics},
  year = {2019},
  volume = {101},
  pages = {1--13}
}
```
(If you used another Ferman et al. paper, replace with the correct citation.)
- Cattaneo, Idrobo & Titiunik (2020): permutation inference methods for comparative designs (helpful for robustness).
```bibtex
@article{cattaneo2020,
  author = {Cattaneo, Matias D. and Idrobo, Nelson and Titiunik, Rocio},
  title = {A Practical Introduction to Regression Discontinuity Designs: 2019 Edition},
  journal = {Technical Report; updated resources available online},
  year = {2020},
  volume = {},
  pages = {}
}
```
(If you prefer a different precise citation, adapt accordingly.)

Explain relevance:
- Abadie et al. (2010) — necessary when you discuss SDID and comparisons to synthetic control. Methodological contrasts should cite the original synthetic control literature.
- Imbens & Lemieux (2008), Lee & Lemieux (2010) — while you do not do RDD, these classic survey references are expected in methodology sections dealing with quasi-experimental inference (and for readers who want canonical background).
- Ferman et al. — raises caution on inference with few pre‑treatment periods and small donor pools; relevant to your long‑run estimates which rely on a few early cohorts.
- Cattaneo et al. / permutation inference literature — helps support permutation placebo inference the paper should include.

5. WRITING QUALITY (critical)
- Prose vs bullets: Major sections are in paragraph form (good). The “three contributions” in the Introduction use italicized short paragraphs but are acceptable.
- Narrative flow: The paper is generally well structured and tells a logical story: motivation → data → identification → results → robustness → welfare. However:
  - The Introduction claims the paper provides the “first credible causal estimate” of EERS effectiveness. That is a strong claim—be careful. There may be state‑level econometric work or program evaluations that estimate population impacts—cite and contrast them explicitly. Tone this down to “the first credible population-level estimate using heterogeneity-robust staggered DiD methods” if that is strictly correct.
  - The “engineering‑econometric gap” claim is interesting but needs careful tempering: engineering estimates differ by program type and assumptions; your back‑of‑envelope converting a multi‑year cumulative ATT into average annual savings requires more transparent calculations (show algebra and assumptions in appendix).
- Sentence quality: Generally crisp. A few long sentences could be tightened. Use active voice and state key insights up front in paragraphs. Avoid periodic long caveats in the middle of sentences.
- Accessibility: Mostly accessible. However, econometric terms (CS‑DiD, Sun‑Abraham, TWFE contamination) should be explained briefly on first use for non‑specialists; you do some of this, but consider adding one small paragraph in Empirical Strategy explaining intuitively why TWFE fails with staggered DiD heterogenous effects.
- Figures/tables: Ensure every figure/table caption is self-contained (estimator, sample, outcome, N). Provide data source and notes in every table/figure. For event studies, add number‑of‑cohorts‑contributing annotations for each event time.

6. CONSTRUCTIVE SUGGESTIONS (to make the paper stronger)
If the paper is to be publishable in a top journal, the following substantive revisions are needed.

A. Strengthen inference
- Provide robust inference for the preferred CS‑DiD ATT: wild cluster bootstrap, permutation tests, and clustered bootstrap for aggregated ATTs and for event‑time estimates. Report p‑values from these procedures and compare to analytical SEs. If CS‑DiD inference is sensitive, downplay claims accordingly.
- Conduct permutation (randomization) inference by randomly assigning “placebo” adoption years to treated states (or randomly assigning treated labels among all states) and show the distribution of placebo ATTs vs the observed ATT. This helps with small‑sample credibility.
- Provide uniform confidence bands for event studies or adjust for multiple comparisons (e.g., Romano & Wolf-type methods or joint F‑tests on pre‑trend leads).

B. Address long‑horizon identification fragility
- Be explicit that long‑run event times (10–15 years) are identified by a small set of early cohorts and/or singletons. Show leave‑one‑out aggregated ATTs and how aggregate ATT changes when you exclude the earliest n cohorts (e.g., exclude all cohorts with ≤ 5 post‑treatment years).
- If possible, augment sample with more pre‑treatment years where available or restrict to balanced panels for certain robustness checks.

C. Add dose‑response / intensity analysis
- Use available measures of program intensity (annual percentage savings target θ_s, DSM program spending per capita or MWh saved targets, program budgets) to estimate continuous treatment effects (two‑way fixed effects with continuous treatment and/or CS‑DiD with continuous dosage). This directly speaks to mechanisms and mitigates concern that the binary indicator obscures heterogeneity.
- If EIA Form 861 DSM spending is messy, present results for the subsample where spending data are reliable and show whether higher spending is associated with larger consumption reductions (dose‑response). That would strengthen causal interpretation.

D. Strengthen placebo and mechanism tests
- Present the industrial electricity placebo regression and event study in the appendix with full inference (SEs, p‑values). Also run placebo tests on outcomes that should not be affected (e.g., state gasoline consumption or electric utility revenue unrelated to residential programs) and show distributions.
- Test for anticipatory behavior by estimating effects using the policy passage date vs implementation date if these differ; if utilities started programs earlier than the statutory adoption year, that matters for timing.
- Examine whether residential bill reductions or price increases are heterogeneous by utility regulatory regime (decoupling vs cost‑of‑service), which helps mechanism (price pass‑through) claims.

E. Pre‑analysis plan and robustness transparency
- Include a short replication checklist in the appendix: list all code files, data versions, and the exact did/fixest packages and versions. You already provide a GitHub link; ensure the repository contains code to reproduce main tables and figures and documentation of random seeds used in bootstrap/permutation tests.

F. Calibrate welfare analysis carefully
- The welfare calculations are useful but rely on many parameters. Move the detailed algebra to the appendix. Present sensitivity analysis over SCC values (e.g., $14, $51, $125 per tCO2) and program cost assumptions ($20–$60/MWh) and show benefit‑cost ranges. Make clear those are illustrative.

G. Improve presentation/clarity of figures and tables
- In every figure, add the number of states/cohorts contributing to each point. For the event study include shaded regions indicating which event times are supported by many vs few cohorts (shaded area or hashed region).
- For group‑ATT plots, provide cohort lists and report the number of treated units per cohort in the caption (you do some of this; make it more explicit).

7. OVERALL ASSESSMENT
- Key strengths
  - Policy‑relevant question with important implications.
  - Good use of modern staggered DiD estimators (Callaway‑Sant'Anna, Sun‑Abraham, SDID).
  - Comprehensive set of robustness exercises and thoughtful sensitivity analysis (Rambachan–Roth honest DiD).
  - Open code and data repository (good reproducibility practice).
- Critical weaknesses
  - Inference fragility: CS‑DiD analytical SEs are reported but robust small‑sample inference (wild bootstrap / permutation) for CS‑DiD is not shown; TWFE bootstrap shows weak significance, which contrasts with CS‑DiD results. This inconsistency must be reconciled.
  - Long‑horizon event‑time estimates are supported by very few cohorts / singletons. The paper sometimes makes strong claims about 5–8% long‑run effects despite identification being driven by a handful of states.
  - The “dose” of treatment (program spending / target stringency) is not used in main identification; a continuous treatment analysis would strengthen mechanistic claims.
  - Placebo and joint pre‑trend tests need to be formalized and fully reported (p‑values, joint tests, permutation distributions).
  - Some literature is missing (synthetic control foundational papers and inference cautions), and the claim “first credible causal estimate” should be toned and carefully positioned with respect to earlier program evaluations and micro studies.
- Specific suggestions for improvement (recap)
  - Add robust inference for CS‑DiD (wild bootstrap and permutation tests), present bootstrap p‑values and CIs for main ATT and event‑time estimates.
  - Present formal joint pre‑trend tests and adjust for multiple comparisons in event study.
  - Add dose‑response analysis using program intensity / spending.
  - Report permutation/placebo inference and leave‑one‑out sensitivity for aggregated ATT.
  - Tone down long‑run claims and present them as suggestive unless robust inference is obtained.
  - Add the missing methodological references (Abadie et al., Imbens & Lemieux, Ferman et al., etc.) and position contribution relative to program evaluation literature.
  - Make figures and captions fully self‑contained and show cohort counts per event time.

8. DECISION (required)
I recommend major revision. The research question is important and the author uses appropriate modern estimators, but the paper’s inference is not yet sufficiently robust nor are long‑run claims sufficiently supported by identified variation to warrant acceptance at a top general interest journal. The manuscript is promising and likely salvageable, but substantial additional empirical work (robust inference, dose‑response analyses, formal pre‑trend/placebo testing, and clearer positioning with respect to literature) is required.

DECISION: MAJOR REVISION